Breast cancer is mainly sub-classified by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) neu status and these are strongly related to the pattern of metastases, in terms of site-specific relapse, early/late metastasis, survival outcomes, and prognosis. This evidence concerns the gene ERBB2 and breast carcinoma.